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A STUDY OF COMORBIDITY IN PSYCHOACTIVE 
SUBSTANCE DEPENDENCE PATIENTS 
PANKAJ KISORE, NAROTTAM LAL, J.K.TRIVEDI, P.K.DALAL, VIMAL M. AGA 
The study assessed the lifetime prevalence of comorbidity in forty three DSM III-R opioid and alcohol 
dependent patients. A total lifetime prevalence rate of 60.5% was found. The results are discussed axis 
wise and compared with previous relevant studies. There was no significant difference in comorbidity 
between the opioid and alcohol Dependent groups. Comorbidity on both Axis I and II were high, but 
there was no significant difference in the presence of Axis I disorders between patients with and without 
personality disorders. The paper also reports upon the temporal relationships amongst the co-occur-
ring psychiatric disorders. 
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INTRODUCTION 
Until the publication of the DSM III-R (APA, 
1987), syndromal comorbidity was largely ignored. 
Most of the hierarchial exclusionary rules of the 
DSM III were dropped in the revised version, allow-
ing clinicians to give "multiple diagnoses when dif-
ferent syndromes occur together in one episode of 
illness" (APA, 1987). DSM III-R incorporated a 
general rule for deciding which one of the several 
diagnoses is to be the "principal diagnosis" - that 
condition which is chiefly responsible for occasion-
ing the evaluation or admission, and may be the 
cause of interference in functioning. The issue of 
comorbidity has now assumed center stage in 
psychiatric research, which has led investigators to 
comment that it may be one of the most important 
advancements in psychiatric nosology in this cen-
tury (Sabshin, 1991). 
Comorbidity of substance use disorders have 
been assessed using the DIS/DSM III (Rose et al, 
1989; Regier et al, 1990), and the SADS-L/RDC 
(Rounsaville et al, 1982). Studies using the 
SCID/DSM III-R have focussed on specific disor-
ders such as personality disorders (Nace et al, 1991) 
or schizophrenia (Dixon et al, 1991). The present 
study was undertaken as it is difficult to translate 
older studies onto newer diagnostic criteria, and also 
because these older studies did not distinguish be-
tween substance "abuse" and "dependence". 
The aim was to assess the lifetime prevalence of 
comorbidity in patients with psychoactive substance 
dependence on the multi-axial DSM III-R classifica-
tion system, and compare opioid dependent and 
alcohol dependent patient groups, on socio-
demographic and clinical variables, as well as to 
assess the temporal relationships between the multi-
ple co-occurring psychiatric disorders. 
MATERIAL AND METHODS 
Patients registered in the deaddiction clinics of 
the OPD's of K.G. 's Medical College, Lucknow and 
Nur Manzil Psychiatric Center, Lucknow, attending 
on specified days, provided the source of the study 
sample. Eighty eight patients with alcohol depend-
ence syndrome, drug dependence (morphine type) 
and non-dependent abuse of alcohol and drugs (mor-
phine type) were screened and forty three males 
were found suitable for the study according to the 
DSM III-R criteria: three patients with opioid de-
pendence and twenty with alcohol dependence. 
A semi-structured proforma was used to record 
sociodemographic variables and history of drug 
abuse. Patients were then administered the Struc-
tured Clinical Interview for DSM III-R (SCID) for 
Axis I and II disorders - Hindi version. Subjects were 
also evaluated on the Severity of Psychosocial Stres-
sor Scale (SPSS: APA, 1987) for Axis IV and V 
disorders. Finally, a thorough physical examination 
and investigations, if necessary, were done for 
coding on Axis III. We used the' interference proce-
dure' for identifying the DSM III-R 'principal 
diagnosis' (APA, 1987) and the 'temporal proce-
dure' for identifying the 'primary diagnosis' (De-
Rutter et al, 1989), this term being used hence forth 
to indicate 'the diagnosis that chronologically 
preceded all others' (Sanderson et al, 1990) and not 
to indicate the relative severity of the concurrent 
disorders, as used by some workers (Leckman et al, 
1983; Barlow et al, 1986). The relative onset of the 
concurrent disorders was rated on the basis of the 
patients' historical report during assessment. 
Chi square test was used as a test of association 
between the variables studied (Fisher's Exact test 
used where values in any cell were less than 5). 
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RESULTS 
Sociodemograph'c variables: No significant 
difference could be tound between patients with 
comorbidity and those without, on the 
sociodemographic variables studied (age, religion, 
education, marital status, occupation, income and 
domicile). When analysed for differences between 
the two substance dependence groups, patients with 
opioid dependence were significantly younger than 
those with alcohol dependence (X = 5.0553, df=l; 
p<0.05), belonged to a significantly lower per capita 
income group (Fisher's test p=0.0402) and differed 
significantly in domicile, 69.6% patients with 
opioid dependence and all patients with alcohol 
dependence coming from urban backgrounds 
(Fishers' test p=0.(X)76). 
Extent of comorbidity: Lifetime prevalence of 
comorbidity in 60.5% of the total sample (65.0% in 
alcohol dependence and 56.6% in opioid depend-
ence). The difference between the two groups was 
not statistically significant. 
Table 1 
Multiple Diagnoses: Lifetime Prevalence 
Number of Opioid Alcohol Total 
concurrent Dependence Dependence 
diagnosis (n=23) (%) (n=20) (%) (n=43)(%) 
1 
2 
3 
4 
5 
10 (43.5) 
7 (30.4) 
5 (21.7) 
-
1 (4.4) 
7 (35.0) 
7 (35.0) 
5 (25.0) 
1 (5.0) 
• 
17 (39.5) 
14 (32.5) 
10 (23.3) 
1 (2.3) 
1 (2.3) 
Multiple Diagnoses: Two diagnoses were 
present in 32.5% and more than two in 27.9% of the 
total patients (Fable 1). 
Comorbidity on Axis I: The commonly co-oc-
curring disorders (Table 2) were mood disorders, 
other substance abuse, sexual dysfunctions, 
psychotic disorders and anxiety disorders. No sig-
nificant difference was found between the two 
groups. 
Comorbidity on Axis II: Among patients with 
comorbidity, 53.8% with opioid dependence and 
30.8% with alcohol dependence had personality dis-
orders, a non-significant difference (Table 3). 
72.7% of the patients with a diagnosis of Axis II also 
had an Axis I diagnosis, while 46.9%. of those 
without a personality disorder had Axis I disorders, 
this difference not being statistically significant. 
Table 2 
Lifetime Prevalence of Comorbidity of Axis I 
(among patients in whom comorbidity ws present) 
Comorbid Opioid 
Disorder Dependence 
(Axisl) n=13 
Number (%) 
A. Mood Disorders
 a 
Absent 10 (76.9%) 
Present 3 (23.1%) 
B. Psychiatric Disorders
b 
Absent 11 (84.6%) 
Present 2 (15.4%) 
C. Sexual Dysfunctions
c 
Absent 11 (84.6%) 
Present 2 (15.4%) 
D. Other Substance Abuse
d 
Absent 8 (61.5%) 
Present 5 (38.5%)' 
E. Anxiety Disorders
 e 
Absent 12 (92.3%) 
Present 1 (7.7%) 
Alcohol 
Dependence 
n=13 
Number (%) 
7 
6 
12 
1 
9 
4 
10 
3 
13 
(53.8%) 
(46.2%) 
(92.3%) 
(7.7%) 
(69.2%) 
(30.8%) 
(76.9%) 
(23.1%) 
(100.0%) 
Fisher's exact test (opioid vs alcohol dependence) 
a: p = 0.2046; b: p = 0.5; c: p = 0.3224; d: p = 0.2075 
e: p = 0.5 
' Both alcohol and cannabis abuse in one patient. 
Table 3 
Lifetime Prevalence of Comorbidity of Axis II 
(among patients in whom comorbidity was present) 
Axis II Opioid Alcohol 
Comorbid Dependence Dependence 
Disorders number (%) number (%) 
Absent 
Present* 
6 (46.2%) 
7 (53.8%) 
Antisocial ! 
Borderline 
Narcissistic 
Histrionic 
Passive Aggressive 
Dependent 
3 (23.9%) 
1 (7.7%) 
1 (7.7%) 
1 (7.7%) 
1 (7.7%) 
1 (7.7%) 
(69.2%) 
(30.8%) 
1 
(7.7%) 
(7.7%) 
(7.7%) 
(7.7%) 
(7.7%) 
Fisher's exact test (opioid dependence vs. alcohol 
dependence) p = 0.2314 
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Tabic 4 
Co-occurance of the Comorbid Oiaordera 
Substance 
Abuse 
n=8 
Depressive 
Disorders 
n=7 
Psychotic 
Disorders 
n=2 
Sexual 
Dysfunction 
n=6 
Personality 
Disorders 
n=11 
Mania 
n=2 
Anxiety 
Disorders 
n=1 
Substance Abuse 
Depressive Disorders 
Psychotic Disorders 
Sexual Dysfunction 
Personality Disorders 
Mania 
Anxiety Disorders 
Tables 
Chronolgoy of Comorbidity 
Lifetime Substance Substance 
Comorbidity. dependence dependence 
preceding the subsequent to the 
comorbkf diisorder comorbid disorders 
Opoid Alcohol Opoid Alcohol 
1 Mood Dlsordere (n=9) 
Bipolar Manic 0 
Bipolar Depressed 1 
Major Depression 2 
Dysthymia 0 
2. Psychotic Disorders (n*3) 
Schizophrenia 0 
Schizophreniform 0 
3. Anxiety Disorders (n=1) 
Panic & Agoraphobia 0 
4. Other Substance Abuse (n=7)' 
Alcohol 0 
Opoid 0 
Cannabis 0 
5. Sexual Dyefunctlons (n=6) 
0 
6. Pereonalhy Disorders (n=11)* 
0 
1 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
1 
2 
0 
0 
2 
0 
3 
1 
0 
0 
3 
0 
0 
1 
0 
2 
1 
8 
Note: The figures in the table show number of 
individual disorders, and not number of patients. 
One patient had both alcohol and cannabis abuse 
together, while two patients had two personality 
disorders each (Histrionic + Narcissistic PD; Nar-
cissistic + Passive Aggressive PD), the sum of 
figures in category 4 thus being 8, and in category 6 
being 13. 
Co-occurrence of the comorbid disorders: The 
tendency of comorbid disorders to co-exist is well 
demonstrated in Table 4. 
- Of eight patients with other substance 
abuse, five also had a diagnosis on Axis II. 
- Of seven patients with depressive disor-
ders, four had concurrent sexual dysfunc-
tions and three had a comorbid diagnosis 
on Axis II. 
- Of seven patients with sexual dysfunctions, 
four also had depressive disorders, and two 
had a diagnosis on Axis II. 
- Of the eleven patients with personality dis-
orders, five had comorbid other substance 
abuse, three had depressive disorders and 
two had sexual dysfunctions. 
Chronology of comorbidity: In order to under-
stand the chronology of comorbidity, the onset of the 
psychoactive substance dependence and the comor-
bid disorders is compared (Table 5). In five out of 
nine patients, the mood disorder came primary to the 
psychoactive substance dependence, four of these 
patients having dysthymia. In the remaining four 
patients with mood disorders, substance dependence 
had preceded the mood disorder in terms of chronol-
ogy of development. Similarly, in the one patient 
with schizophreniform disorder, the psychotic 
episode developed after he had already developed 
alcohol dependence, the latter thus being the primary 
diagnosis. 
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DISCUSSION 
The present study assessed the lifetime 
prevalence of comorbidity in patients with alcohol 
or opioid dependence, and the chronology of such 
comorbidity, using an observational, analytical 
study design of retrospective pattern. The small 
sample size (n=43) was the single major drawback 
of the study, due to which analyses were possible 
only on broad groups of disorders and comorbidity 
of individual disorders could not be ascertained. The 
sample, though unlikely to be representative of the 
general population, may however show a trend 
amongst psychiatric treatment seeking populations 
in tertiary level psychiatric hospitals. The possibility 
of a recall bias cannot be ignored either, as the study 
was based on retrospective recall. 
About sixty percent of all patients had comorbid 
disorders: 65% of the alcohol dependent and 56.5% 
of the opioid dependent patients. The figures are 
slightly lower than those previously reported: 84.2% 
in a similar sample (Ross et al, 1988); 86.9% among 
opioid addicts only (Rounsaville et al, 1982). Com-
munity studies report lower rates; in a re-analysis of 
the ECA data, a lifetime prevalence of 32.7% 
(Regier et al, 1990), and in a community study in 
India, a figure of 6.81% was reported (Dube & 
Handa, 1971), reflecting the difference between 
treatment seeking and non-treatment seeking 
populations. The higher prevalence of comorbidity 
in treatment seeking populations (Berkson's fallacy: 
Berkson, 1946) may suggest that the presence of 
comorbid disorders provide additional motivation 
for patients to seek treatment (Rounsaville et al, 
1982). 
A large proportion of subjects in this study had 
multiple diagnoses, again comparable to the figures 
of earlier studies (Rounsaville et al, 1982). The 
common comorbid Axis I disorders in this study: 
mood disorders, sexual dysfunctions and other 
psychoactive substance abuse were also reported by 
other workers (Weissman et al, 1980; Rounsaville et 
al, 1982; Ross et al, 1988; Regier et al, 1990). The 
low prevalence of anxiety disorders in our study as 
opposed to the high rates in other studies quoted 
above, may be due to these patients pres anting to our 
OPD with primarily anxiety related symptoms and 
hence being missed by our screening procedure. 
At least one lifetime diagnosis on Axis II was 
present in 25.6% of patients. These results are not 
comparable with those of other workers; Nace et al 
(1991) reported 57% Axis II disorders in substance 
abusers using SCID, but they did not differentiate 
between substance abuse and dependence, and had 
also included patients dependent on substances other 
than alcohol and opioids, unlike our sample. While 
other workers (Rounsaville et al, 1982; Ross et al, 
1988) have shown specific comorbid disorders to 
vary with changes in sociodemographic parameters, 
the small sample size of the present study did not 
permit an analysis of the variation of individual 
disorders with sociodemographic variables. 
Regarding the chronology of comorbidity (Table 
5) it is apparent that sexual dysfunctions, anxiety 
disorders, other substance abuse, personality disor-
ders and schizophrenia, all preceded the principal 
diagnosis in all cases, as also in four out of seven 
cases with depressive disorders. The one 
schizophreniform disorder and three out of seven 
cases of depressive disorders developed subsequent 
to the substance dependence. These findings are 
comparable to those of other studies. Christie et al 
(1988) found in their sample that three-fourths of the 
patients had an anxiety or depressive disorders 
which preceded the substance use disorder, while 
Ross et al (1988) found antisocial personality disor-
der in all cases and major depression and 
schizophrenia in most cases preceding the substance 
use disorder, though a considerable majority (23 to 
40%) of the latter disorders also followed substance 
use disorders. However, the vital question of estab-
lishing a casual relationship between substance de-
pendence and concurrent disorders remains largely 
unanswered. For this, the following criteria are sug-
gested: 
- A strong statistical association between 
disorders known to be causally related; 
The association should be present in 
samples from different settings including 
community specific populations, counsell-
ing centers and psychiatric hospitals; 
- Relationships between the severity of the 
concurrent disorders should be probed; 
- Confounding variables like genetic 
predisposition and socio-demographic 
variables, should be identified and 
removed; 
- Usage of the terms 'primary' and 
'principal' strictly according to the opera-
tional criteria defined by DSM III-R and 
Sanderson et al (1990), to prevent any am-
biguity. 
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While the principal diagnosis is important in so 
far as it "will be the main focus of attention or 
treatment" (DSM III-R; APA, 1987), it is the tem-
poral sequence of comorbid disorders that are im-
portant in etiological investigations of disorders. 
Clearly, a patient who has continuous major depres-
sion for two years, and who develops multiple 
somatic aches and pains in, say, the last two months, 
is different from a patient with long standing multi-
ple somatic symptoms who has developed depres-
sion in the last few months. While the principal 
diagnosis of both patients may be major depression, 
it will be the primary diagnosis that is of both 
therapeutic and etiological importance. Adherence 
to such criteria may go a long way in partly unravell-
ing what had rightly been termed, as the 'multi-
faceted clinical profile' of psychiatric patients. 
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